{"disease":{"id":"canavan-disease","name":"canavan disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT04126005","title":"Natural History Study of Patients With Canavan Disease (CANinform Study)","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Aspa Therapeutics","has_results":false},{"nct_id":"NCT04998396","title":"A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Aspa Therapeutics","has_results":false},{"nct_id":"NCT04833907","title":"rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":24,"lead_sponsor_name":"Myrtelle Inc.","has_results":false},{"nct_id":"NCT05317780","title":"Canavan-Single Patient IND","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Florida","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}